title: Atherosclerosis in genetically obese mice: the mutants obese, diabetes, fat, tubby, and lethal yellow.
abstract: Mice with five different mutations conferring an obese or diabetic phenotype were evaluated for fatty streak lesions after consuming an atherogenic diet containing 15% fat and 1.25% cholesterol (wt/wt) for 14 weeks. The five mutations, fat, obese, tubby, diabetes, and lethal yellow, are maintained as congenic strains with C57BL/6J (B6) or C57BL/KsJ (BKs) as genetic backgrounds. None of the mutants exhibited accelerated fatty streak lesion formation; the mutant fat had aortic lesions comparable in size to those of its control strain, and the mutants obese, diabetes, tubby, and lethal yellow had significantly reduced lesion area in comparison to controls. Although B6 and BKs are closely related strains, we observed that the BKs strain was more prone to early-stage atherogenesis. Fatty streak lesion area was twice as large in BKs mice than those found in B6 mice; likewise, in comparison, the mutants obese and diabetes had larger lesions if they were carried as congenic strains in the BKs rather than the B6 genetic background. Plasma triglycerides, total cholesterol, high-density lipoprotein cholesterol (HDL-C), and combined low-density and very-low-density lipoprotein cholesterol (LDL-C and VLDL) levels were also measured in the mice. Lipid profiles differed among the mutant mice, but in general, elevations in plasma total cholesterol, triglycerides, and HDL-C were observed. Whereas the hypertriglyceridemia and hypercholesterolemia are consistent with an atherogenic lipid profile, HDL-C levels, which are normally decreased in individuals with non-insulin-dependent diabetes mellitus, were increased in the mouse mutants.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Jackson Laboratory, Bar Harbor, ME 04609.
authors.forename: P M
authors.initials: PM
authors.lastname: Nishina
authors.forename: J K
authors.initials: JK
authors.lastname: Naggert
authors.forename: J
authors.initials: J
authors.lastname: Verstuyft
authors.forename: B
authors.initials: B
authors.lastname: Paigen
mesh_terms: D000818:Animals; D001161:Arteriosclerosis / Q000209:etiology*; D008076:Cholesterol, HDL / Q000097:blood / Q000737:chemistry; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000097:blood / Q000235:genetics*; D008055:Lipids / Q000097:blood; D051379:Mice; D008817:Mice, Mutant Strains / Q000097:blood / Q000235:genetics; D009765:Obesity / Q000097:blood / Q000150:complications* / Q000235:genetics*; D010641:Phenotype
chemical_list: D008076:Cholesterol, HDL; D008055:Lipids